HPV 16 E2 binding sites 1 and 2 become more methylated than E2 binding site 4 during cervical carcinogenesis

Journal of Medical Virology

Volumn 87, Issue 6, 2015, Pages 1022-1033

  Leung, Tsin Wah ^a   Liu, Stephanie S ^a   Leung, Rebecca C Y ^a   Chu, Mandy M Y ^a   Cheung, Annie N Y ^a   Ngan, Hextan Y S ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia; E2 binding sites methylation; Human papillomavirus (HPV) 16; Human papillomavirus (HPV) 18

Indexed keywords

VIRUS PROTEIN; DNA BINDING PROTEIN; E2 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; PROTEIN E7; TUMOR MARKER; VIRUS DNA;

ARTICLE; BINDING SITE; CARCINOGENESIS; CERVICAL CANCER CELL LINE; DNA EXTRACTION; DNA MODIFICATION; HUMAN PAPILLOMAVIRUS TYPE 16; PROTEIN BINDING; PROTEIN METHYLATION; PYROSEQUENCING; TRANSCRIPTION INITIATION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS GENOME; ADULT; AGED; DNA METHYLATION; EPITHELIUM; FEMALE; GENETICS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 18; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PATHOLOGY; TUMOR CELL LINE; UTERINE CERVIX; UTERINE CERVIX DYSPLASIA; VIROLOGY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS - 18; HUMAN PAPILLOMAVIRUS TYPE 16;

ADULT; AGED; ATYPICAL SQUAMOUS CELLS OF THE CERVIX; BINDING SITES; BIOMARKERS, TUMOR; CARCINOGENESIS; CELL LINE, TUMOR; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DNA METHYLATION; DNA, VIRAL; DNA-BINDING PROTEINS; EPITHELIUM; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS;

EID: 84926521770     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24129     Document Type: Article

References (50)

1. Androphy EJ, Lowy DR, Schiller JT. 1987. Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA. Nature 325:70-73.
2. Arias-Pulido H, Peyton CL, Joste NE, Vargas H, Wheeler CM. 2006. Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol 44:1755-1762.
3. Badal S, Badal V, Calleja-Macias IE, Kalantari M, Chuang LS, Li BF, Bernard HU. 2004. The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation. Virology 324:483-492.
4. Bediaga NG, Acha-Sagredo A, Guerra I, Viguri A, Albaina C, Ruiz Diaz I, Rezola R, Alberdi MJ, Dopazo J, Montaner D, Renobales M, Fernández AF, Field JK, Fraga MF, Liloglou T, de Pancorbo MM. 2010. DNA methylation epigenotypes in breast cancer molecular subtypes. Breast Cancer Res 12:R77.
5. Bhattacharjee B, Sengupta S. 2006. CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2. Virology 354:280-285.
6. Boulet GA, Benoy IH, Depuydt CE, Horvath CA, Aerts M, Hens N, Vereecken AJ, Bogers JJ. 2009. Human papillomavirus 16 load and E2/E6 ratio in HPV16-positive women: Biomarkers for cervical intraepithelial neoplasia >or = 2 in a liquid-based cytology setting?. Cancer Epidemiol Biomarkers Prev 18:2992-2999.
7. Brandsma JL, Sun Y, Lizardi PM, Tuck DP, Zelterman D, Haines GK, 3rd, Martel M, Harigopal M, Schofield K, Neapolitano M. 2009. Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy. Virology 389:100-107.
8. Centeno F, Ramirez-Salazar E, Garcia-Villa E, Gariglio P, Garrido E. 2008. TAF1 interacts with and modulates human papillomavirus 16 E2-dependent transcriptional regulation. Intervirology 51:137-143.
9. Chan KY, Ozcelik H, Cheung AN, Ngan HY, Khoo US. 2002. Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer. Cancer Res 62:4151-4156.
10. Dell G, Wilkinson KW, Tranter R, Parish J, Leo Brady R, Gaston K. 2003. Comparison of the structure and DNA-binding properties of the E2 proteins from an oncogenic and a non-oncogenic human papillomavirus. J Mol Biol 334:979-991.
11. Demeret C, Desaintes C, Yaniv M, Thierry F. 1997. Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes. J Virol 71:9343-9349.
12. Doeberitz M, Vinokurova S. 2009. Host factors in HPV-related carcinogenesis: Cellular mechanisms controlling HPV infections. Arch Med Res 40:435-442.
13. Dong G, Broker TR, Chow LT. 1994. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements. J Virol 68:1115-1127.
14. Dostatni N, Lambert PF, Sousa R, Ham J, Howley PM, Yaniv M. 1991. The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex. Genes Dev 5:1657-1671.
15. Fontaine V, van der Meijden E, de Graaf J, ter Schegget J, Struyk L. 2000. A functional NF-kappaB binding site in the human papillomavirus type 16 long control region. Virology 272:40-49.
16. Hines CS, Meghoo C, Shetty S, Biburger M, Brenowitz M, Hegde RS. 1998. DNA structure and flexibility in the sequence-specific binding of papillomavirus E2 proteins. J Mol Biol 276:809-818.
17. Hirochika H, Hirochika R, Broker TR, Chow LT. 1988. Functional mapping of the human papillomavirus type 11 transcriptional enhancer and its interaction with the trans-acting E2 proteins. Genes Dev 2:54-67.
18. Ho CM, Lee BH, Chang SF, Chien TY, Huang SH, Yan CC, Cheng WF. 2011. Integration of human papillomavirus correlates with high levels of viral oncogene transcripts in cervical carcinogenesis. Virus Res 161:124-130.
19. Hong D, Ye F, Chen H, Lu W, Cheng Q, Hu Y, Xie X. 2008. Distribution of human papillomavirus genotypes in the patients with cervical carcinoma and its precursors in Zhejiang Province, China. Int J Gynecol Cancer 18:104-109.
20. Hou SY, Wu SY, Chiang CM. 2002. Transcriptional activity among high and low risk human papillomavirus E2 proteins correlates with E2 DNA binding. J Biol Chem 277:45619-45629.
21. Jackson K, Soutto M, Peng D, Hu T, Marshal D, El-Rifai W. 2011. Epigenetic silencing of somatostatin in gastric cancer. Dig Dis Sci 56:125-130.
22. Kalantari M, Calleja-Macias IE, Tewari D, Hagmar B, Lie K, Barrera-Saldana HA, Wiley DJ, Bernard HU. 2004. Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. J Virol 78:12762-12772.
23. Kalantari M, Lee D, Calleja-Macias IE, Lambert PF, Bernard HU. 2008. Effects of cellular differentiation, chromosomal integration and 5-aza-2'-deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell lines. Virology 374:292-303.
24. Kim K, Garner-Hamrick PA, Fisher C, Lee D, Lambert PF. 2003. Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J Virol 77:12450-12459.
25. Lee ES, Issa JP, Roberts DB, Williams MD, Weber RS, Kies MS, El-Naggar AK. 2008. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: Comparison with methylation-specific PCR technique and clinical significance. Clin Cancer Res 14:2664-2672.
26. Li R, Knight J, Bream G, Stenlund A, Botchan M. 1989. Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome. Genes Dev 3:510-526.
27. Liu SS, Leung RC, Chan KK, Cheung AN, Ngan HY. 2010. Evaluation of a newly developed GenoArray human papillomavirus (HPV) genotyping assay and comparison with the Roche Linear Array HPV genotyping assay. J Clin Microbiol 48:758-764.
28. Liu SS, Leung RC, Chan KY, Chiu PM, Cheung AN, Tam KF, Ng TY, Wong LC, Ngan HY. 2004. P73 expression is associated with the cellular radiosensitivity in cervical cancer after radiotherapy. Clin Cancer Res 10:3309-3316.
29. Liu SS, Tsang PC, Chan KY, Cheung AN, Chan KK, Leung RC, Ngan HY. 2008. Distribution of six oncogenic types of human papillomavirus and type 16 integration analysis in Chinese women with cervical precancerous lesions and carcinomas. Tumour Biol 29:105-113.
30. Mirabello L, Schiffman M, Ghosh A, Rodriguez AC, Vasiljevic N, Wentzensen N, Herrero R, Hildesheim A, Wacholder S, Scibior-Bentkowska D, Burk RD, Lorincz AT. 2012. Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia. Int J Cancer 132:1412-1422.
31. Moribe T, Iizuka N, Miura T, Kimura N, Tamatsukuri S, Ishitsuka H, Hamamoto Y, Sakamoto K, Tamesa T, Oka M. 2009. Methylation of multiple genes as molecular markers for diagnosis of a small, well-differentiated hepatocellular carcinoma. Int J Cancer 125:388-397.
32. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527.
33. Piyathilake CJ, Macaluso M, Alvarez RD, Chen M, Badiga S, Edberg JC, Partridge EE, Johanning GL. 2011. A higher degree of methylation of the HPV 16 E6 gene is associated with a lower likelihood of being diagnosed with cervical intraepithelial neoplasia. Cancer 117:957-963.
34. Rajeevan MS, Swan DC, Duncan K, Lee DR, Limor JR, Unger ER. 2006. Quantitation of site-specific HPV 16 DNA methylation by pyrosequencing. J Virol Methods 138:170-176.
35. Rapp B, Pawellek A, Kraetzer F, Schaefer M, May C, Purdie K, Grassmann K, Iftner T. 1997. Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2. J Virol 71:6956-6966.
36. Sanchez IE, Dellarole M, Gaston K, de Prat Gay G. 2008. Comprehensive comparison of the interaction of the E2 master regulator with its cognate target DNA sites in 73 human papillomavirus types by sequence statistics. Nucleic Acids Res 36:756-769.
37. Soeda E, Ferran MC, Baker CC, McBride AA. 2006. Repression of HPV16 early region transcription by the E2 protein. Virology 351:29-41.
38. Steenbergen RD, Walboomers JM, Meijer CJ, van der Raaij-Helmer EM, Parker JN, Chow LT, Broker TR, Snijders PJ. 1996. Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: Activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q. Oncogene 13:1249-1257.
39. Steger G, Corbach S. 1997. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J Virol 71:50-58.
40. Sun C, Reimers LL, Burk RD. 2011. Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer. Gynecol Oncol 121:59-63.
41. Tan SH, Leong LE, Walker PA, Bernard HU. 1994. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J Virol 68:6411-6420.
42. Thain A, Jenkins O, Clarke AR, Gaston K. 1996. CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specific DNA sequences. J Virol 70:7233-7235.
43. Turan T, Kalantari M, Calleja-Macias IE, Cubie HA, Cuschieri K, Villa LL, Skomedal H, Barrera-Saldana HA, Bernard HU. 2006. Methylation of the human papillomavirus-18 L1 gene: A biomarker of neoplastic progression? Virology 349:175-183.
44. Turan T, Kalantari M, Cuschieri K, Cubie HA, Skomedal H, Bernard HU. 2007. High-throughput detection of human papillomavirus-18 L1 gene methylation, a candidate biomarker for the progression of cervical neoplasia. Virology 361:185-193.
45. Van Tine BA, Kappes JC, Banerjee NS, Knops J, Lai L, Steenbergen RD, Meijer CL, Snijders PJ, Chatis P, Broker TR, Moen PT, Jr., Chow LT. 2004. Clonal selection for transcriptionally active viral oncogenes during progression to cancer. J Virol 78:11172-11186.
46. Vinokurova S, von Knebel Doeberitz M. 2011. Differential methylation of the HPV 16 upstream regulatory region during epithelial differentiation and neoplastic transformation. PloS One 6:e24451.
47. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
48. Wiley DJ, Huh J, Rao JY, Chang C, Goetz M, Poulter M, Masongsong E, Chang CI, Bernard HU. 2005. Methylation of human papillomavirus genomes in cells of anal epithelia of HIV-infected men. J Acquir Immune Defic Syndr 39:143-151.
49. Woodman CB, Collins SI, Young LS. 2007. The natural history of cervical HPV infection: Unresolved issues. Nat Rev Cancer 7:11-22.
50. Wright TC, Jr., Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2007. 2006 Consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. J Low Genit Tract Dis 11:223-239.